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INTRODUCTION
Healthcare advocacy is an integral tool for physicians 
to ensure that patients are treated to the best of their abil-
ity. Advocacy should be part of a physician’s armamentar-
ium, regardless of specialty. In the ever-changing political 
climate of the United States, health policy and reform are 
turning into common hot-button issues, not only at the 
state level but also at the federal level of government. In 
contrast to politicians and other policy experts, plastic 
surgeons are uniquely positioned to advocate on behalf 
of their patients and their profession through their direct 
healthcare experience and clinical knowledge. A recent 
JAMA editorial by former Administrator of the Centers for 
Medicare and Medicaid Services, Dr. Donald Berwick said, 
“the work of a physician as a healer cannot stop at the 
door of an office, the threshold of an operating room, or 
the front gate of a hospital … To try to avoid the political 
fray through silence is impossible … Either engage, or as-
sist in the harm.”1
The purpose of this special topics article is to provide 
plastic surgeons with a basic framework of knowledge re-
garding the importance of health policy advocacy and also 
to review recent successes in advocacy related to plastic 
surgery. We aim to empower plastic surgeons to be dili-
gent advocates and to utilize their influence on policy.
POLICY AND ADVOCACY 101
Policy can be broadly defined as a set of rules, prin-
ciples, or actions adopted by an institution for the benefit 
of its pertinent constituents or stakeholders, which are 
enforceable. Advocacy can be employed by a spectrum of 
individuals, ranging from local hospital personnel regard-
ing implementation of institutional policy to government 
officials advocating for sweeping federal policies. On the 
one end of the policy spectrum, hospital systems can cre-
ate policy that requires surgeons to double glove or wear 
a surgical cap versus a bouffant. On the other end of the 
spectrum, policy can be adopted by Congress that requires 
insurance companies to provide coverage for breast can-
cer patients who desire breast reconstruction as in the case 
of the Women’s Health and Cancer Rights Act.2 Advocacy 
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is defined as taking action to support, oppose, or recom-
mend policy or law, and in this current climate, physician 
advocacy is more important than ever before.3
Healthcare policy advocacy within plastic surgery 
stands the potential to impact education, training, prac-
tice of plastic surgery, and individual patient care.3 When 
considering policy and how it may impact the practice of 
plastic surgery, all key stakeholders who stand to ben-
efit from or be impacted by a specific piece of policy 
should be considered. Key stakeholders in healthcare 
and health policy to be considered are often summa-
rized into the 5 P’s: Patients, Providers, Purchasers, Pay-
ers, and the Public (Fig. 1). Healthcare policy has the 
potential to impact all aforementioned stakeholders, 
and taking each one into consideration is essential for 
meaningful advocacy.
Although no two pieces of policy are implemented 
through precisely the same process, there is a general 
lifecycle of policy development that physician advo-
cates should be familiar with, which can, in turn, shed 
light on where advocates can intervene through advo-
cacy (Fig. 2). As advocates, plastic surgeons can identify 
problems and make them known to policy makers and 
healthcare administrators. By doing so, it will effectively 
influence both agenda setting and policy formulation to 
solve the identified issues through policy. For example, 
plastic surgeons have identified the need for insurance 
coverage of comprehensive pediatric congenital malfor-
mation. Because of this, it is hoped that the American 
Society of Plastic Surgeons (ASPS) continues to convey 
this issue to gain bipartisan support to draft new legis-
lation. As a specific piece of policy is being considered 
for adoption, plastic surgeons can advocate support or 
opposition, depending on the policy’s impact on the 5 
P’s. Lastly, plastic surgeons can evaluate policy through 
research to analyze how it impacts practice and patient 
care. These results can further influence agenda setting 
and subsequent policy formulation.
AVENUES FOR ADVOCACY
The landscape of healthcare in the United States is 
uniquely complex and continuously evolving at the fed-
eral, state, and even institutional levels. Plastic surgeons 
are positioned to advocate at all levels for the betterment 
of patient care and the profession. Many physicians, in-
cluding plastic surgeons, are unaware of the authority and 
expertise they stand to assist with changes.
There are numerous avenues through which plastic 
surgeons can advocate. Some examples include, state 
capitols, social media, blogging, community and institu-
tion education, and serving on committees and councils 
in professional organizations and at their own home in-
stitution.
The field of plastic surgery is fortunate to have a strong 
existing infrastructure for advocacy thanks to organiza-
tions such as the ASPS. One key cornerstone to the ASPS 
advocacy presence includes PlastyPAC.4 This is a politi-
cal action committee (PAC) led by plastic surgeons who 
work in collaboration with fellow physicians, patients, and 
policy experts to advocate, educate, influence, and pro-
vide support for political campaigns and candidates that 
advance and reinforce key issues within the field of plastic 
surgery.
Despite this existing framework, contributions to Pla-
styPAC are limited. In fact, there are 9 states throughout 
the country without a single contributor to this specific 
PAC and 16 additional states with 3 or less contributors.4 
This advocacy branch of the ASPS and its associated PAC 
could be even stronger and more representative of the en-
tire profession with assistance and input from additional 
plastic surgeons throughout the country through engage-
ment, or better understanding of the advantages of par-
ticipating in political advocacy.
Participating in political advocacy can take many forms 
and include multiple levels of involvement.3 The simplest 
way to become engaged is through contacting the office 
of a Congressperson or executive through letter writing, 
phone calls, or email message. The format for letters and 
emails along with suggested rules of engagement of such 
messaging are simple. They are usually available within 
the Society’s advocacy representatives and are available as 
a supplement to this article. It is important to provide an 
introduction along with a description of expertise and ex-
perience in the field that qualifies and further buttresses 
Fig. 1. Summary of the 5 p’s when considering relevant stakeholders 
for a given policy.
Fig. 2. Summary depiction of the policy cycle, which is applicable to 
all levels of government.
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the perspective provided in the message. Additionally, a 
brief description of rationale for contacting the individ-
ual should be incorporated early in the message to ori-
ent its recipient. In the body of the message, a concise 
but detailed perspective should be provided and contain 
evidence to support opinions related to the issue at hand. 
The message should conclude cordially and with an in-
vitation to discuss the matter further at a later date with 
provided contact information. To summarize, the message 
should be collegial, brief, and inviting to explore the is-
sue further collaboratively. Additionally, social media can 
play a role in advocacy. Platforms such as Twitter provide a 
platform, wherein plastic surgeons are able to share their 
perspective on a given issue and discuss with colleagues, 
policy makers, and other constituents/stakeholders inter-
ested in the topic.
Advocacy can also be much more involved and per-
sonable in the form of face-to-face meetings, which can 
be set up through contacting political figure’s office indi-
vidually or on behalf of an association/organization (ie, 
ASPS). Similar to the aforementioned means of messag-
ing, meetings are often brief, which requires professional 
and persuasive efforts in a concise timeframe focusing on 
a specific issue or piece of policy. More intimate forms of 
advocacy such as face-to-face meetings can lead to fruitful 
professional collaboration between plastic surgeons and 
policy makers/executives and can evolve into ad hoc/
impromptu policy advising and communications as the 
healthcare landscape evolves.
The emphasis of health policy advocacy is to move the 
needle in the right direction for the betterment of patient 
care and the profession, specifically as it relates to plastic 
surgery. Letter writing, Tweets, and 20-min meetings may 
seem inconsequential, but this is untrue. These sorts of ap-
proaches can be effective and indeed are the sole means 
of amplifying the voice of plastic surgeons in the politi-
cal arena. The effects of such efforts can be compounded 
further when a larger number of plastic surgery advocates 
step into the arena of policy.
As physicians, we are all engrossed in our practices 
endless hours a day and sometimes something as simple 
as emailing a congressperson seems to escape us. Over the 
years the responses for lack of engagement by our peers 
have included, “too busy,” “it doesn’t affect my practice,” 
“I won’t make a difference,” “someone else will do it,” “I 
don’t like my congressperson,” etc. The general apathy 
that exists remains the primary barrier to PAC contribu-
tions as well.
As will be discussed below, advocates in plastic surgery 
have already been successful in such efforts and should 
facilitate and inspire more plastic surgeons to become in-
volved.
FEDERAL ADVOCACY
Key advocacy issues identified by the ASPS in the past 
undoubtedly have the potential to impact plastic surgeons, 
their practice, and their patients. In 2017 alone, the ASPS 
submitted 42 letters in support or opposition of different 
pieces of legislation relating to the field of plastic surgery. 
Advocacy on behalf of the ASPS played an integral role 
in the Breast Cancer Patient Education Act (BCPEA) of 
2015.5 The BCPEA’s passage was a more recent success 
that came in the wake of the Women’s Health and Cancer 
Rights Act (WHCRA) of 1998, which required insurance 
coverage for breast cancer patients who desired breast 
reconstruction. Advocacy on behalf of the ASPS was in-
strumental in gaining support and eventually passing the 
Women’s Health and Cancer Rights Act.
The BCPEA aims to increase patient awareness and 
education of reconstructive options after mastectomy 
secondary to breast cancer. It also provides information 
pertaining to insurance companies and coverage options. 
Many patients, especially medically underserved popula-
tions, remain unaware of breast reconstruction and pros-
theses postmastectomy as an option that is covered by 
health insurance providers.6–8
Stakeholder engagement, not only including plastic 
surgeons, other physicians, and politicians but also pa-
tients themselves was instrumental in the passage of the 
BCPEA. Many patients accompanied plastic surgeons in 
advocating for this policy by sharing personal stories and 
experiences with federal legislators. This form of stake-
holder engagement through sharing of firsthand expe-
riences unquestionably also contributed to legislators’ 
support of the BCPEA. This underscores the importance 
of stakeholder engagement in policy advocacy.
The ASPS has identified this as a key issue and is con-
tinuously attempting to raise patient awareness of this 
surgical option for breast cancer patients in the wake of 
passage of the BCPEA. Support by plastic surgeons was in-
strumental in passing of the BCPEA, in part, due to their 
clinical knowledge, extensive experience with the specific 
patient population who stood to benefit from the bill’s 
passage, and insight regarding education, access, and 
shortcomings associated with insurance companies and 
costs related to breast reconstruction.
Additionally, the ASPS is diligently working to increase 
patient safety by supporting policy that ensures patients 
are seeking care from board-certified plastic surgeons. 
Numerous stories have emerged in the media regarding 
unethical care, unacceptable complications, and mislead-
ing advertisements involving uncertified physicians. This 
is an issue that is likely to persist unless plastic surgeons 
and other clinicians advocate for policy change at local, 
state, or federal levels.
The ASPS has also recognized the importance of in-
creasing the number of plastic surgery staff and faculty po-
sitions available to medical school graduates and trainees, 
respectively. In past years, the number of plastic surgery 
services rendered has increased, and it is important to 
maintain an adequate workforce to meet those needs.9,10 
By advocating for increased funding for Medicare-funded 
graduate medical education (GME) residency and fellow-
ship positions, the ASPS continues to support this issue.
The ASPS is also working to increase health insurance 
coverage for additional types of reconstructive surgery. 
For example, ASPS recently endorsed the Ensuring Last-
ing Smiles Act, which would require health insurance cov-
erage for reconstructive surgery of congenital craniofacial 
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defects.11 Advocacy pertaining to this issue was the prima-
ry topic addressed and acted upon at the ASPS Advocacy 
Summit in June of 2018.
RESEARCH-RELATED ADVOCACY
Successful advocacy efforts through the Plastic Surgery 
Foundation have established research databases which 
tackle important clinical questions. Some of these databas-
es include the National Breast Implant Registry (NBIR), 
Patient Registry and Outcomes For breast Implants and 
anaplastic large cell Lymphoma etiology and Epidemiol-
ogy (PROFILE), and the General Registry of Autologous 
Fat Transfer. National Breast Implant Registry plans to be 
a collaborative effort in which patient safety will be moni-
tored through post-market surveillance and device track-
ing information. The Patient Registry and Outcomes For 
breast Implants and anaplastic large cell Lymphoma etiol-
ogy and Epidemiology registry is a centralized repository 
for important data regarding breast implant-associated 
anaplastic large cell lymphoma to obtain a better under-
standing of its etiology, epidemiology, and surveillance. 
Regulation related to fat grafting and regenerative medi-
cine is of increasing interest, and the General Registry of 
Autologous Fat Transfer database will aim to contribute 
clinical practice guidelines through evidence-based data.
STATE-LEVEL ADVOCACY
Plastic surgeon advocacy has also contributed success-
ful lobbying of numerous policy pieces at the state level of 
government as well, part of which included 155 letters sub-
mitted to state legislatures and regulatory bodies. In the 
state of Indiana, for example, plastic surgeons opposed 
legislation that would have permitted expansion of den-
tal surgical scope to include the maxillofacial region. In 
Ohio, plastic surgeons implemented policy changes per-
mitting mid-level providers and certified medical assistants 
to use and operate laser devices under the supervision 
of a qualified physician. Successful efforts in Louisiana 
culminated in approval of legislation for a breast recon-
struction education. Plastic surgeons’ advocacy has not 
solely been limited to issues directly influencing the field 
of plastic surgery but also healthcare infrastructure and 
medical practice in general. In numerous states, plastic 
surgeons and PlastyPAC have actively opposed legislation 
that would permit advanced practice providers to practice 
independently and also have advocated against expansion 
of naturopaths’ scopes of practice.
LOCAL-LEVEL ADVOCACY
At more local levels of government, plastic surgeons 
have been active in promoting the field of plastic surgery 
and access to plastic surgery as well. Breast Reconstruction 
Awareness days are held annually in cities and municipali-
ties throughout the country during breast cancer aware-
ness month in October. Breast Reconstruction Awareness 
days take many forms, ranging from fundraising efforts 
through dine-out nights, to presence at local community 
and sporting events.
“NEGATIVE ADVOCACY”—PREVENTING 
ONEROUS POLICY
Sometimes, plastic surgeons may believe that nothing 
has been done to prevent certain practices. In those cases, 
the overall perception is that policy advocacy does not af-
fect their practice, and part of why this misperception exists 
is by the nature of some forms of advocacy, which can entail 
the advocacy against enactment of onerous legislation. As 
mentioned, advocacy is a 2-way street that can work in both 
directions—both support and opposition of policy. For 
example, when the federal government was considering a 
national cosmetic surgery tax, practicing plastic surgeons 
in New Jersey had and were currently enduring a similar 
tax at a state level.12 Their advocacy from this experience 
with a similar policy within their own state rendered their 
input and perspectives immensely helpful in describing 
the possible downsides and detriments to enacting a simi-
lar policy at the federal level. Due, in part, to the onerous 
efforts of the ASPS advocacy team, a national cosmetic tax 
was never passed. Another example includes the current 
efforts to increase patient awareness of what is the scope 
of plastic surgery, prevent nonsurgeons from performing 
complex surgical procedures, prevent false or misleading 
advertisement of plastic surgery procedures to assure safety 
of plastic surgery patients.13 However, for plastic surgeons 
not engaged in advocacy, these worthwhile and notewor-
thy efforts are more likely to go unnoticed than supportive 
policy advocacy, which is much more likely to be more pub-
licized and subject of discussion in the media.
RESIDENT AND MEDICAL STUDENT 
ENGAGEMENT
Medical students and residents are the future advo-
cates for our patients and profession and the future lead-
ers in the field of plastic surgery that will be responsible for 
changes. Recognizing this, resident and medical student 
involvement in advocacy is paramount to imprint the im-
portance of healthcare literacy and advocacy. Attendance 
to the ASPS Advocacy Summit has been encouraged and 
marketed. Furthermore, there is a move to increase op-
portunities for resident representation on PlastyPAC’s 
Legislative Advocacy Committee and other leadership op-
portunities. One example of the importance of resident 
and medical student involvement in advocacy is the GME 
policy. The legislators engagement is noticeably more gen-
uine when a future resident speaks of the proposed resi-
dency shortages than a plastic surgeon already in practice. 
On this case, residents and medical students are involved 
as stakeholders and advocates, similar to how patients 
were integral in advocating for passage of the BCPEA.
THE EVOLUTION OF ASPS ADVOCACY
The second annual ASPS Advocacy Summit took place 
June 26–28, 2018 in Washington, D.C.14 The meeting in-
volved sessions and roundtable discussions for plastic 
surgeons, advocacy/policy experts, representatives from 
PlastyPAC, physician advocates, policymakers, and po-
litical analysts to collaborate on common interests. The 
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summit allowed plastic surgeons to gain knowledge, expe-
rience, and tactics relating to advocacy, which could then 
be applied toward issues important to them and their in-
stitution. Moreover, ASPS selects policy priorities based 
on those roundtables and members’ input. The general 
membership is polled yearly and policy priority issues at 
both the federal and state levels are evaluated and priori-
tized.
Before the Advocacy Summit, in years prior multistate 
regional fly-ins were organized for plastic surgeons to 
meet with their respective legislators to advocate hot topic 
healthcare issues relevant to the practice of plastic surgery. 
These experiences, while effective, were less comprehen-
sive and collaborative in contrast to the new annual sum-
mit that brings a larger number of participants to the table 
increasing the presence of stakeholders.
CONCLUSIONS
Some plastic surgeons have engaged in policy advoca-
cy and those who have not, are poised to make beneficial 
contributions. Advocacy, in this way, stands to better the 
profession along with plastic surgery patients. It is impor-
tant to engage and remain active in the arena of policy. 
A great framework for lobbying and advocacy has been 
developed and exists thanks to the work by the ASPS and 
other foundations, organizations, and societies, and it is 
time that plastic surgeons felt empowered to capitalize 
upon existing infrastructure.
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